Overall, our results suggest that the establishment of an effective tumor-killing environment composed of favorable cell types, such as DCs, CD8+ memory T-cells, and NK cells, as well as important chemokines, including CCL19, CXCL10, and XCL1 relies on all aspects of the combination therapy. Here, XCL1 is linked to neoplasm.